(VIANEWS) – Eli Lilly and Company (LLY), Surgery Partners (SGRY), Sterling Construction Company (STRL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Eli Lilly and Company (LLY)
19.4% sales growth and 50.75% return on equity
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $5.77.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 130.27. Meaning, the purchaser of the share is investing $130.27 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.75%.
Yearly Top and Bottom Value
Eli Lilly and Company’s stock is valued at $751.64 at 01:22 EST, below its 52-week high of $820.61 and way higher than its 52-week low of $422.06.
Moving Average
Eli Lilly and Company’s value is below its 50-day moving average of $764.96 and way higher than its 200-day moving average of $654.02.
2. Surgery Partners (SGRY)
13.4% sales growth and 4.76% return on equity
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Earnings Per Share
As for profitability, Surgery Partners has a trailing twelve months EPS of $0.01.
PE Ratio
Surgery Partners has a trailing twelve months price to earnings ratio of 2539. Meaning, the purchaser of the share is investing $2539 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.76%.
Moving Average
Surgery Partners’s value is under its 50-day moving average of $26.41 and way below its 200-day moving average of $29.74.
Volume
Today’s last reported volume for Surgery Partners is 715838 which is 25.36% below its average volume of 959159.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 28.6% and positive 42.1% for the next.
Yearly Top and Bottom Value
Surgery Partners’s stock is valued at $25.39 at 01:22 EST, way under its 52-week high of $45.79 and way above its 52-week low of $22.05.
3. Sterling Construction Company (STRL)
13.3% sales growth and 27.22% return on equity
Sterling Construction Company, Inc., a construction company, engages in the heavy civil, specialty services, and residential construction activities primarily in the southern United States, the Rocky Mountain states, California, and Hawaii. The company undertakes various heavy civil construction projects, including highways, roads, bridges, airfields, ports, light rail, water, wastewater and storm drainage systems for the departments of transportation in various states, regional transit authorities, airport authorities, port authorities, water authorities, and railroads. It offers specialty services such as foundations for multi-family homes, parking structures, and other commercial concrete projects for blue-chip end users in the e-commerce, data center, distribution center and warehousing, energy, mixed use, and multi-family sectors. The company also undertakes concrete foundations for single-family homes. In addition, it provides surveying, clearing and grubbing, erosion control, grading, grassing, site excavation, storm drainage, sanitary sewer and water main installation, drilling and blasting, curb and gutter, paving, concrete work, and landfill services. The company was formerly known as Oakhurst Company, Inc. and changed its name to Sterling Construction Company, Inc. in November 2001. Sterling Construction Company, Inc. was founded in 1955 and is headquartered in The Woodlands, Texas.
Earnings Per Share
As for profitability, Sterling Construction Company has a trailing twelve months EPS of $4.79.
PE Ratio
Sterling Construction Company has a trailing twelve months price to earnings ratio of 26.9. Meaning, the purchaser of the share is investing $26.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.22%.
Yearly Top and Bottom Value
Sterling Construction Company’s stock is valued at $128.86 at 01:22 EST, below its 52-week high of $137.63 and way above its 52-week low of $43.65.
4. Laureate Education (LAUR)
5.6% sales growth and 15.16% return on equity
Laureate Education, Inc., together with its subsidiaries, offers higher education programs and services to students through a network of universities and higher education institutions. The company provides a range of undergraduate and graduate degree programs in the areas of business and management, medicine and health sciences, and engineering and information technology through campus-based, online, and hybrid programs. It also offers specialized courses for technical and vocational training; and senior high school. Its services are provides in Mexico, Peru, and the United States. The company was formerly known as Sylvan Learning Systems, Inc. and changed its name to Laureate Education, Inc. in May 2004. Laureate Education, Inc. was founded in 1989 and is headquartered in Miami, Florida.
Earnings Per Share
As for profitability, Laureate Education has a trailing twelve months EPS of $0.84.
PE Ratio
Laureate Education has a trailing twelve months price to earnings ratio of 19.08. Meaning, the purchaser of the share is investing $19.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.16%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 80% and 17.4%, respectively.
Yearly Top and Bottom Value
Laureate Education’s stock is valued at $16.03 at 01:22 EST, under its 52-week high of $16.60 and way above its 52-week low of $11.34.
Volume
Today’s last reported volume for Laureate Education is 600148 which is 19.85% below its average volume of 748862.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 1.51B for the twelve trailing months.
